Latest Breaking News On - Contactmike moyerlifesci advisorstel - Page 1 : comparemela.com

Long-term Survival Data from Longeveron s ELPIS 1 Trial Presented at the 2023 Scientific Sessions of the American Heart Association

Long-term Survival Data from Longeveron s ELPIS 1 Trial Presented at the 2023 Scientific Sessions of the American Heart Association
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesContactmike moyerlifesci advisorstelSunjay kaushalNational institute of health heartCompany quarterlyLongeveron incLongeveron or companyNational heartBlood instituteScientific sessions of the american heart associationDrug administrationExchange commissionExtended follow up data show continuedTransplant free survivalSupport continued investigationAging related frailty

Longeveron Reports Third Quarter 2023 Results and Provides Corporate Update

Longeveron Reports Third Quarter 2023 Results and Provides Corporate Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesContactmike moyerlifesci advisorstelDevelopment expensesAmerican heart associationExchange commissionLongeveron incInternational investors dialNational centerLongeveron or companyScientific sessions of the american heart associationJuntendo university hospital tokyoCompany to hold conference callCompany phaseExchange commission onTop line resultsTrial affirm safety profile

Longeveron (LGVN) Issues Letter to Stockholders

Longeveron (LGVN) Issues Letter to Stockholders
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Jeffrey pfefferContactmike moyerlifesci advisorstelKhoso baluchLisa locklearWael hashadchief executive officerlongeveron incExchange commissionLongeveron incExchange commission onLongeveron or companyAging related frailtyWa el hashadChief executive officerFellow stockholdersChief scientific officerUnder joshHypoplastic left heart syndrome

Long-term Survival Data from Longeveron s ELPIS 1 Trial Accepted for Presentation at the 2023 Scientific Sessions of the American Heart Association

Long-term Survival Data from Longeveron s ELPIS 1 Trial Accepted for Presentation at the 2023 Scientific Sessions of the American Heart Association
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesContactmike moyerlifesci advisorstelSunjay kaushalExchange commissionLongeveron incLongeveron or companyExchange commission onDrug administrationAmerican heart associationScientific sessions of the american heart associationAging related frailtyLong term transplant free survival is improvedHypoplastic left heart syndromeCell based therapyScientific sessionsRare pediatric disease designation

Longeveron (LGVN) Appoints Dr Nataliya Agafonova as Chief Medical Officer

Longeveron (LGVN) Appoints Dr Nataliya Agafonova as Chief Medical Officer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Ardea bioscienceBristol myers squibbNataliya agafonovaContactmike moyerlifesci advisorstelUkrainian research institute of oncologyProduct development chairExchange commissionClinical developmentUkrainian national medical universityKharkov state university hospitalLongeveron incLongeveron or companyChief medical officerWa el hashadChief executive officerOtsuka pharmaceutical